BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2126902)

  • 1. [Local lysis of peritoneovenous shunt thrombosis with rt-PA].
    Herold G; Seifried E; Hildebrand P; Stange EF; Ditschuneit H
    Z Gastroenterol; 1990 Nov; 28(11):626-9. PubMed ID: 2126902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Local fibrinolytic therapy in thrombotic complications of peritoneovenous shunt].
    Billmann P; Volk BA; Schölmerich J; Hasler K; Wilms H
    Z Gastroenterol; 1986 Aug; 24(8):426-9. PubMed ID: 3765747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Local thrombolysis in peripheral arterial occlusion].
    Hess H
    Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvaging procedures for dysfunctional peritoneovenous shunt.
    Hu RH; Lee PH
    Hepatogastroenterology; 2001; 48(39):794-7. PubMed ID: 11462926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis with recombinant human tissue-type plasminogen activator in patients with peripheral artery and bypass graft occlusions.
    Graor RA; Risius B; Lucas FV; Young JR; Ruschhaupt WF; Beven EG; Grossbard EB
    Circulation; 1986 Sep; 74(3 Pt 2):I15-20. PubMed ID: 3091288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chylous ascites: resolution after Denver peritoneovenous shunt.
    Turner WW
    South Med J; 1983 Apr; 76(4):539. PubMed ID: 6601302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic stent-shunt after orthotopic liver transplantation in a patient with early recurrence of portal hypertension of unknown origin.
    Nolte W; Canelo R; Figulla HR; Kersten J; Sattler B; Münke H; Hartmann H; Ringe B; Ramadori G
    Z Gastroenterol; 1998 Feb; 36(2):159-64. PubMed ID: 9544499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombolysis of modified Blalock-Taussig shunts in childhood with recombinant tissue-type plasminogen activator].
    Klinge J; Hofbeck M; Ries M; Schaf J; Singer H; von der Emde J
    Z Kardiol; 1995 Jun; 84(6):476-80. PubMed ID: 7653087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiological insertion and management of peritoneovenous shunt.
    Bratby MJ; Hussain FF; Lopez AJ
    Cardiovasc Intervent Radiol; 2007; 30(3):415-8. PubMed ID: 17278034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peritoneovenous diversion using the LeVeen shunt in the treatment of refractory ascites after liver transplantation].
    Mabrut JY; de la Roche E; Adham M; Ducerf C; Baulieux J
    Ann Chir; 1998; 52(7):612-7. PubMed ID: 9805798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneovenous shunts for malignant ascites.
    Sonnenfeld T; Tydén G
    Acta Chir Scand; 1986 Feb; 152():117-21. PubMed ID: 3953206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant tissue plasminogen activator to declot dialysis fistulas.
    Boobes Y; al Hassan H; Neglen P; Obeid K; Denour N
    J Nephrol; 1997; 10(2):107-10. PubMed ID: 9238617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneovenous shunting for intractable ascites.
    Tyden G; Samnegård H; Thulin L
    Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinolysis with rt-PA in peripheral arterial occlusions].
    Hess H; Mietaschk A; Becker-Lienau C
    Klin Wochenschr; 1988; 66 Suppl 12():135-6. PubMed ID: 3126341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peritoneovenous shunting in intractable ascites of cirrhosis. Results of a prospective study on improving prognostic factors].
    Hillaire S; Labianca M; Smadja C; Grange D; Franco D
    Gastroenterol Clin Biol; 1988 Oct; 12(10):681-6. PubMed ID: 3220223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant tissue plasminogen activator (rt-PA) as first-line therapy for declotting of haemodialysis access.
    Andriani M; Drago G; Bernardi AM; Da Porto A; De Luca M; Riegler P; Biasia F; Pinzani A
    Nephrol Dial Transplant; 1995; 10(9):1714-9. PubMed ID: 8559494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calibrated portacaval H-graft shunt in variceal hemorrhage. Long-term results.
    Fernandez-Aguilar JL; Bondia Navarro JA; Santoyo Santoyo J; Suarez-Muñoz MA; Perez-Daga A; Ramirez Plaza C; Mera Velasco S; de la Fuente Perucho A
    Hepatogastroenterology; 2003; 50(54):2000-4. PubMed ID: 14696452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Percutaneous implant of Denver peritoneovenous shunt: a new opportunity for the interventional radiologist].
    Spreafico C; Patelli G; Lanocita R; Di Tolla G; Marchianò A; Frigerio L; Garbagnati F; Ticha V; Damascelli B
    Radiol Med; 2001 Sep; 102(3):154-8. PubMed ID: 11677458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Local thrombolytic treatment of spontaneous intracerebral hemorrhage with plasminogen activator (rt-PA). Indications and limits].
    Schaller C; Rohde V; Hassler W
    Nervenarzt; 1995 Apr; 66(4):275-81. PubMed ID: 7783814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.